<?xml version="1.0" ?>
<text author="Carlos Moctezuma-Velazquez, Ernesto Márquez-Guillén, Aldo Torre" dateCollected="2019-11-03" id="autogum_academic_doc626" shortTile="obesity-liver-transplant" sourceURL="https://www.mdpi.com/2072-6643/11/11/2552/htm" speakerCount="0" speakerList="none" title="Obesity in the Liver Transplant Setting" type="academic">
<head>
<s>
2
.
</s>
<s>
Obesity
Before
Liver
Transplantation
</s>
</head>
<head>
<s>
2.1
.
</s>
<s>
How
Should
Obesity
be
Defined
in
Patients
with
Cirrhosis
Considered
for
LT
?
</s>
</head>
<p>
<s>
The
first
obstacle
is
to
define
obesity
in
this
population
.
Elamparast
et
al.
recently
summarized
the
most
commonly
used
definitions
in
this
group
of
patients
:
</s>
</p>
<dl class="html-bullet">
<s>
<dt id="">
-
</dt>
</s>
<s>
<dd>
BMI
≥
30
kg/m2
(
Asian
population
:
≥25
kg/m2
)
;
</dd>
</s>
<s>
<dt id="">
-
</dt>
</s>
<s>
<dd>
Percentage
of
fat
mass
≥28
%
in
men
and
≥40
%
in
women
;
</dd>
</s>
<s>
<dt id="">
-
</dt>
</s>
<s>
<dd>
Waist
circumference
˃102
cm
in
men
and
˃88
cm
in
women
(
Asian
population
:
A
waist
circumference
˃90
cm
in
men
and
˃80
cm
in
women
)
;
</dd>
</s>
<s>
<dt id="">
-
</dt>
</s>
<s>
<dd>
Visceral
fat
area
≥100
cm2
on
abdominal
computed
tomography
.
</dd>
</s>
</dl>
<p>
<s>
The
use
of
BMI
has
several
limitations
in
patients
with
decompensated
cirrhosis
,
as
reflected
by
the
fact
that
sarcopenia
outperforms
BMI
as
a
predictor
of
outcomes
after
LT
.
</s>
<s>
First
of
all
,
a
high
BMI
may
be
due
to
fluid
overload/ascites
,
and
not
obesity
per
se
,
as
exemplified
in
a
study
in
which
adjusting
BMI
for
the
liters
of
ascites
drained
at
the
time
of
LT
resulted
in
moving
one-fifth
of
patients
from
one
BMI
category
to
a
lower
one
.
</s>
<s>
Also
,
BMI
gives
no
information
about
body
composition
:
</s>
<s>
It
cannot
tell
the
difference
between
muscle
,
subcutaneous
,
or
visceral
adipose
tissue
,
which
have
different
implications
.
</s>
<s>
Studies
looking
at
body
composition
on
cross-sectional
imaging
have
found
that
sarcopenia
and
low
subcutaneous
adipose
tissue
,
but
not
BMI
,
are
associated
with
mortality
in
male
and
female
patients
with
cirrhosis
,
respectively
.
</s>
<s>
Excessive
visceral
fat
when
associated
with
sarcopenia
,
a
term
known
as
sarcopenic
obesity
,
is
also
associated
with
increased
mortality
.
</s>
<s>
In
the
case
of
living
donor
liver
transplant
(
LDLT
)
patients
,
sarcopenia
,
myosteatosis
,
and
the
visceral-to-subcutaneous-adipose-tissue
ratio
,
but
not
visceral
or
subcutaneous
tissue
on
their
own
,
have
been
associated
with
mortality
.
</s>
<s>
This
reinforces
the
fact
that
more
than
the
size
of
a
patient
,
which
is
what
the
BMI
stands
for
,
it
is
the
composition
that
matters
.
</s>
<s>
For
the
same
reasons
,
waist
circumference
is
not
the
best
method
to
assess
obesity
in
these
patients
.
</s>
<s>
Trying
to
circumvent
some
of
these
limitations
,
the
European
Association
for
the
Study
of
the
Liver
guidelines
for
nutrition
in
patients
with
cirrhosis
recommend
to
adjust
the
BMI
for
the
confounding
effect
of
fluid
retention
(
i.
e.
,
dry-BMI
)
,
though
there
is
no
perfect
correlation
between
BMI
and
ascites
,
and
in
fact
,
BMI
corrected
for
ascites
drained
at
the
time
of
LT
failed
to
predict
relevant
outcomes
after
LT
.
</s>
<s>
Likewise
,
a
modified
BMI
calculated
by
multiplying
BMI
(
kg/m2
)
by
serum
albumin
(
g/L
)
with
the
intention
of
compensating
for
volume
overload
was
found
of
no
use
to
predict
clinical
outcomes
.
</s>
</p>
<p>
<s>
In
conclusion
,
when
available
,
we
suggest
obesity
be
defined
according
to
the
visceral
fat
area
on
body
composition
analysis
,
especially
in
the
research
setting
,
because
the
impact
of
obesity
on
LT
may
be
modified
by
the
coexistence
of
sarcopenia
,
myosteatosis
,
and/or
low
subcutaneous
adipose
tissue
.
</s>
</p>
<head>
<s>
2.2
.
</s>
<s>
Should
Morbidly
Obese
Patients
be
Listed
for
LT
?
</s>
</head>
<p>
<s>
Some
LT
programs
consider
morbid
obesity
a
relative
contraindication
for
LT
based
on
the
latest
recommendations
from
the
American
Association
for
the
Study
of
the
Liver
.
</s>
<s>
However
,
evidence
evaluating
the
role
of
obesity
on
outcomes
after
LT
is
conflicting
.
</s>
<s>
When
needed
,
patients
with
severe
and
morbid
obesity
do
benefit
from
LT
,
meaning
they
live
longer
than
they
would
do
without
it
,
and
LT
in
these
patients
strays
far
away
from
being
futile
,
with
five-year
survival
rates
well
above
50
%
.
</s>
<s>
Evidence
so
far
does
not
support
using
a
strict
BMI
cutoff
to
deny
someone
candidacy
for
LT
,
however
obesity
is
frequently
associated
with
other
conditions
that
may
be
contraindications
for
LT
such
as
cardiovascular
disease
,
cancer
,
renal
dysfunction
,
and
pulmonary
hypertension
.
</s>
<s>
Also
,
obesity
is
a
risk
factor
for
NAFLD
,
which
though
traditionally
considered
to
have
similar
post-LT
outcomes
to
those
of
other
etiologies
of
liver
disease
,
may
in
fact
have
lower
one-year
survival
due
to
cardiovascular
and
cerebrovascular
diseases
.
</s>
<s>
In
summary
,
more
than
obesity
itself
,
it
is
the
sum
of
the
comorbidities
of
the
individual
patient
that
determines
LT
outcomes
and
as
such
,
morbid
obesity
should
not
be
considered
on
its
own
a
contraindication
for
LT
,
but
in
turn
should
trigger
a
rigorous
pre-LT
assessment
to
carefully
select
potential
recipients
,
as
discussed
below
.
</s>
</p>
</text>
